Medivation (Drug Discovery) Overview
- Status
-
Acquired/Merged
- Employees
-
628
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14.3B
- Investors
-
3
Medivation (Drug Discovery) General Information
Description
Operator of a biopharmaceutical company focused on the development and commercialization of medically innovative therapies. The company develops novel, small molecule drugs to treat serious diseases for which there are limited treatment options, thereby offering hope to critically ill patients and their families.
Contact Information
Website
www.medivation.comCorporate Office
- 525 Market Street
- 36th Floor
- San Francisco, CA 94105
- United States
Corporate Office
- 525 Market Street
- 36th Floor
- San Francisco, CA 94105
- United States
Medivation (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 28-Sep-2016 | $14.3B | Completed | Profitable | ||
| 9. 2PO | 28-May-2009 | Completed | Generating Revenue | |||
| 8. PIPE | 01-Jan-2008 | Completed | Generating Revenue | |||
| 7. PIPE | 10-Sep-2007 | Completed | Generating Revenue | |||
| 6. PIPE | 15-May-2006 | Completed | Generating Revenue | |||
| 5. PIPE | 01-Jan-2006 | Completed | Generating Revenue | |||
| 4. 2PO | 15-Dec-2005 | Completed | Clinical Trials - Phase 2 | |||
| 3. PIPE | 17-Dec-2004 | Completed | Generating Revenue | |||
| 2. Reverse Merger | 17-Dec-2004 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Medivation (Drug Discovery) Comparisons
Industry
Financing
Details
Medivation (Drug Discovery) Competitors (61)
One of Medivation (Drug Discovery)’s 61 competitors is Astellas Pharma, a Corporation company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Sumitomo Pharma (Pharmaceuticals) | Corporation | Mississauga, Canada | ||||
| Melinta Therapeutics | Private Equity-Backed | Parsippany, NJ | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Medivation (Drug Discovery) Signals
Medivation (Drug Discovery) Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BB Biotech | Asset Manager | Minority | ||
| Crown Predator Holdings | Family Office | Minority | ||
| Kearny Venture Partners | Venture Capital | Minority | ||
| Venrock | Venture Capital | Minority |
Medivation (Drug Discovery) Investments & Acquisitions (5)
Medivation (Drug Discovery)’s most recent deal was a Corporate Asset Purchase with BioMarin (Phase III PARP) for . The deal was made on 24-Aug-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioMarin (Phase III PARP) | 24-Aug-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Auransa | 22-Dec-2014 | Seed Round | Discovery Tools (Healthcare) | ||
| CureTech (Pidilizumab Drug) | 23-Oct-2014 | Corporate Asset Purchase | Buildings and Property | ||
| Orion Acquisition Corp. II | 17-Dec-2004 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| 609 Silver Street | Corporate Asset Purchase | Buildings and Property |
Medivation (Drug Discovery) ESG
Risk Overview
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Medivation (Drug Discovery) FAQs
-
Where is Medivation (Drug Discovery) headquartered?
Medivation (Drug Discovery) is headquartered in San Francisco, CA.
-
What is the size of Medivation (Drug Discovery)?
Medivation (Drug Discovery) has 628 total employees.
-
What industry is Medivation (Drug Discovery) in?
Medivation (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Medivation (Drug Discovery) a private or public company?
Medivation (Drug Discovery) is a Private company.
-
What is the current valuation of Medivation (Drug Discovery)?
The current valuation of Medivation (Drug Discovery) is .
-
What is Medivation (Drug Discovery)’s current revenue?
The current revenue for Medivation (Drug Discovery) is .
-
How much funding has Medivation (Drug Discovery) raised over time?
Medivation (Drug Discovery) has raised $161M.
-
Who are Medivation (Drug Discovery)’s investors?
BB Biotech, Crown Predator Holdings, Kearny Venture Partners, and Venrock have invested in Medivation (Drug Discovery).
-
Who are Medivation (Drug Discovery)’s competitors?
Astellas Pharma, Pacira BioSciences, Sumitomo Pharma (Pharmaceuticals), Melinta Therapeutics, and Genentech are some of the 61 competitors of Medivation (Drug Discovery).
-
When was Medivation (Drug Discovery) acquired?
Medivation (Drug Discovery) was acquired on 28-Sep-2016.
-
Who acquired Medivation (Drug Discovery)?
Medivation (Drug Discovery) was acquired by Pfizer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process